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Abstract
Aims/hypothesis It is generally accepted that structural and
functional quantitative imaging of individual islets would be
beneficial to elucidate the pathogenesis of type 1 diabetes. We
here introduce functional optical coherence imaging (FOCI)
for fast, label-free monitoring of beta cell destruction and as-
sociated alterations of islet vascularisation.
Methods NOD mouse and human islets transplanted into the
anterior chamber of the eye (ACE) were imagedwith FOCI, in
which the optical contrast of FOCI is based on intrinsic vari-
ations of the index of refraction resulting in a faster tomo-
graphic acquisition. In addition, the phase sensitivity allows
simultaneous label-free acquisition of vascularisation.
Results We demonstrate that FOCI allows longitudinal quan-
tification of progressive autoimmune insulitis, including the
three-dimensional quantification of beta cell volume, inflam-
mation and vascularisation. The substantially increased back-
scattering of islets is dominated by the insulin–zinc
nanocrystals in the beta cell granules. This translates into a
high specificity for the functional beta cell volume of islets.
Applying FOCI to a spontaneous mouse model of type 1
diabetes, we quantify the modifications of the pancreatic mi-
crovasculature accompanying the progression of diabetes and
reveal a strong correlation between increasing insulitis and
density of the vascular network of the islet.
Conclusions/interpretation FOCI provides a novel imaging
technique for investigating functional and structural
diabetes-induced alterations of the islets. The label-free detec-
tion of beta cell volume and infiltration together with vascu-
larisation offers a unique extension to study ACE-transplanted
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human islets. These results are contributing to a deeper under-
standing of human islet transplant rejection and label-free
in vivo monitoring of drug efficacy.
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Abbreviations
3D Three-dimensional
ACE Anterior chamber of the eye
B6 C57BL/6
CT Computed tomography
dfOCM Dark-field OCM
FOCI Functional optical coherence imaging
FOXP3 Forkhead box P3
GFP Green fluorescent protein
HEV High endothelial venule
IHC Immunohistochemistry
KO Knockout
MAdCAM-1 Mucosal addressin cell adhesion molecule 1
OCM Optical coherence microscopy
OPT Optical projection tomography
xfOCM Extended-focus OCM
Introduction
Diabetes mellitus develops as a functional impairment in in-
sulin production, sometimes in association with insulin resis-
tance. In both major types of diabetes mellitus, the progressive
dysfunction of the beta cell causes the disease development.
While type 1 diabetes is the result of an autoimmune attack on
beta cells, type 2 diabetes is considered to be driven by met-
abolic factors associated with sedentary lifestyle and obesity,
albeit with accumulating evidence of low-grade inflammation.
Modifications of the pancreatic microvasculature are likely to
accompany the progression of both types of diabetes. Alter-
ations in vascular variables, such as transient vasoconstriction,
vasodilation, increased blood flow and vascular leakage, are
necessary preludes to inflammation as they orchestrate the
influx of diverse cell types and affect local homeostasis
[1–6]. To fully appreciate how these events contribute to the
pathogenesis, improved methods allowing longitudinal, high-
resolution monitoring of vascularisation and affected tissues
close to the cellular level during its natural progression are
warranted and constitute the key objectives of this study.
To date, longitudinal non-invasive, intra-vital imaging of
the pancreas has beenmainly restricted to non-optical imaging
modalities such as MRI and computed tomography (CT).
While the medical potential of these modalities is
indisputable, they are limited by a restricted set of reagents
targeting specific tissues and by a relatively low spatial reso-
lution [4, 7, 8]. Optical microscopy on the other hand is main-
ly limited to preclinical studies because of a reduced penetra-
tion depth [9–12]. Optical projection tomography (OPT) has
been used to image the adult mouse pancreas and retrieve the
three-dimensional (3D) and undistorted structure of the tissue
[13]. While OPTcan quantify inflammation at different stages
of disease [14, 15], it is limited by being an ex vivo technique
that requires sample fixation and immunolabelling.
In accordance with these objectives, we opted for a non-
invasive imaging method, extended-focus optical coherence
microscopy (xfOCM) [16], which allows label-free longitudi-
nal visualisation and quantification of pancreatic ducts, blood
vessels and individual islets of Langerhans ex vivo and
in vivo. The technique requires only a two-dimensional scan
to obtain a 3D image. This intrinsic multiplex advantage re-
sults in a fast parallel acquisition of entire depth profiles with-
out depth scanning, with an in vivo penetration depth of
∼300 μm in the pancreas. However, optical pancreas imaging
requires laparotomy, restricting this technique to transversal
studies [17–19]. Recently, the anterior chamber of the eye
(ACE) has been used to study transplanted pancreatic islets
[20–22]. Engrafted on the iris, islets could now be repeatedly
imaged using the mouse eye as a natural body window. Using
this approach, we elucidate important structural and functional
alterations induced during the progression of autoimmune
diabetes.
Methods
Animals Mice of genotype C57BL/6 (B6).Rag2−/− were
backcrossed with NOD mice for the generation of
NOD.Rag2− /− mice, as previously described [23].
NOD.Foxp3-green fluorescent protein (GFP) mice were gen-
erated by speed-congenic backcrossing of the B6.Foxp3-GFP
(Jax stock number 006772) with NOD mice, as previously
described [21]. BALB/c mice were purchased from Taconic
(Ejby, Denmark). All animals were bred and maintained in a
specific pathogen-free environment at the animal facilities at
Lund University. Guinea pigs were purchased from Harlan
Laboratories (Indianapolis, IN, USA). Mice with ZnT8
(also known as Slc30a8) knockout (KO) and littermates were
generated as previously described [24]. The Ethics Committee
at Lund University and the Swiss cantonal veterinary author-
ities approved all experimental animal procedures. Experi-
ments were performed after mice were genotyped, without
randomisation or blinding. No data were specifically included
or excluded.
Pancreatic islet isolation, culture and ACE transplanta-
tion Mouse pancreatic islets were isolated according to the
Diabetologia
protocol previously described [25]. Between 10 and 50 cul-
tured islets were transplanted per eye, as previously described
[21].
For experiments, including the study of healthy control
islet grafts, 6–8-week old BALB/c or B6.Foxp3-GFP recipi-
ent mice were ACE transplanted with islets from BALB/c or
B6.Rag2−/− donors, respectively. For inflamed islet grafts, 10-
week-old NOD.Foxp3-GFP recipient mice were ACE
transplanted with islets from NOD.Rag2−/− donors. Human
islets from non-diabetic cadaver donors were provided by
the Nordic Islet Transplantation Program (www.nordicislets.
org), coordinated by O. Korsgren, Uppsala University, and
were transplanted into 6–8-week-old female NOD.Rag2−/−
mice (see the electronic supplementary materials [ESM]
Methods for details). The study was approved by the Ethics
Committee at Lund University.
Functional optical coherence imagingMouse head and eye-
ball were restrained as previously described [20] and anaes-
thesia was maintained at 1% isoflurane. Functional optical
coherence imaging (FOCI) integrates the xfOCM instrument
equipped with a Zeiss Neofluar objective×10; NA 0.3, Carl
Zeiss (Jena, Germany) with an improved acquisition
(customised optical coherence microscopy [OCM] spectrom-
eter) and optimised scanning modality for longitudinal func-
tional imaging. A fast processing unit allows real-time moni-
toring (structure and blood flow), with a fully equipped plat-
form for small-animal imaging. Details of the xfOCM instru-
ment, data acquisition, scanning protocols and analysis are
given in the ESM Methods.
Immunohistochemistry Graft-bearing eyes or pancreas were
isolated frommice after perfusion with 4% paraformaldehyde/
PBS, cryosectioned parallel to the iris (section thickness
8–10 μm) and subjected to immunohistochemical staining as
previously described [21] (see ESM Methods).
Ex vivo imaging with dark-field optical coherence micros-
copy Cryosections were mounted with DABCO mounting
medium and imaged using the dual system combining dark-
field OCM (dfOCM) [26] with confocal fluorescence
(ESM Fig. 1) (see ESM Methods).
Statistics Groups were compared by the Mann–Whitney test
or unpaired Student’s t test, as indicated in the respective
figure legend, and data are expressed as means ± SEM.
Results
Beta cell specificity inOCM The optical contrast in xfOCM
is based on the scattering characteristics of the investigated
tissue. As we have previously shown, xfOCM imaging can
be used to identify pancreatic islets in surgically exposed
pancreases of live animals; the strong light scattering ob-
served correlates strongly with insulin-producing beta cells
[17]. As OCM is sensitive to changes in refractive index
and because pancreatic beta cells have a high zinc content
[27], we hypothesised that the origin of the strong OCM
signal is dominantly caused by the zinc-insulin crystals in
the pancreatic beta cells. To test this hypothesis, thick pan-
creas sections of ZnT8–KO mice, which lack zinc-insulin
crystals in the secretory granules of beta cells [24, 27], were
subjected to immunohistochemistry (IHC) using anti-
insulin antibodies and analysed simultaneously by OCM
and confocal fluorescence microscopy. In order to suppress
the specular reflection from the cover slip, we used a dark-
field OCM (dfOCM) configuration combined with a con-
focal fluorescence channel (ESM Fig. 1). Figure 1 shows
transverse virtual sections at the selected depth position of
this dfOCM image stack and the corresponding fluores-
cence images. While control pancreases showed a good
correlation between dfOCM and insulin staining (Fig. 1a),
the dfOCM signal in the ZnT8-KO mouse pancreases was
significantly diminished (Fig. 1b, d), indicating that zinc
within beta cells contributes to the OCM signal. In addi-
tion, we imaged the pancreases of guinea pigs, as they have
a divergent insulin unable to form the hexameric crystals
with zinc [28]. Therefore, beta cells in guinea pigs contain
both insulin and zinc, but do not store insulin as zinc-
insulin crystals. Guinea pig beta cells did not show a strong
scattering in dfOCM images (Fig. 1c, d). While it is likely
that additional, unidentified nanocrystals contribute to the
islet scattering, these findings underline that this label-free
approach provides a high specific contrast for the function-
al beta cell volume.
Longitudinal quantification of beta cell volume and islet
vascularisation using FOCI Having established that the
xfOCM signal specifically reflects the beta cell volume,
we next applied this technique in longitudinal studies.
While longitudinal imaging of the pancreas in situ is fea-
sible, the necessary laparotomy does not allow the reloca-
tion of the same islet at successive imaging sessions. To
overcome this, we combined xfOCM with longitudinal im-
aging of islets transplanted into the ACE of recipient mice
to establish FOCI (ESM Figs 2 and 3). Isolated syngeneic
islets were transplanted into the ACE of healthy mice and
repeatedly imaged by FOCI. Using this approach, we dem-
onstrated how the islets were growing during the course of
the study (Fig. 2a–e). These data extend previous reports
based on two-photon microscopy showing that, after an
init ial phase of vascularisat ion, syngeneic islets
transplanted into the ACE are sustained and function over
several months [20, 25].
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Using FOCI, we next visualised and quantified the micro-
vasculature in the transplanted islets over a 2month period. As
illustrated in Fig. 2a–d, f, we found that, in parallel with islet
growth, re-vascularisation of the grafted islet occurred rapidly
over the first 2 weeks to form a capillary network.
An important advantage of the label-free FOCI technology
is the potential to obtain high-resolution images of tissue
structures, such as the human islets of Langerhans, that are
not easily subjected to labelling with specific cues. We
exploited these features for assessing islets isolated from hu-
man organ donors and transplanted into the ACE of immuno-
deficient NOD.Rag2−/−mice. All 14 individual NOD.Rag2−/−
recipient mice receiving human islet grafts accepted multiple
islet grafts. Depending on the quality of the donor material
obtained, the successful engraftment of individual islets
varied between three and five and up to 15 islets out of ap-
proximately 20 injected islets. Successfully engrafting islets
displayed evidence of beginning re-vascularisation within
2–3 days and become fully re-vascularised 2–3 weeks later.
In these islets, no signs of rejection could be detected for up to
25 weeks. As illustrated in Fig. 3 and as suggested in a pre-
vious report [29], transplanted islets were found to be func-
tional and secreting insulin after ACE transplantation. The
anatomical organisation of the transplanted islets was intact,
with beta cells scattered between alpha and delta cells and
distributed over the entire islet volume (Fig 3a). This well-
established difference from the anatomical organisation of
rodent islets is also illustrated in the non-homogeneous tissue
structure revealed in the OCM image of the human islet
(Fig. 3b).
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Fig. 1 Ex vivo dfOCM imaging of pancreas and beta cell specificity of
the OCM signal. Pancreas sections of ZnT8+/+ controls (a), ZnT8−/−mice
(b) or guinea pigs (c) were analysed by IHC using anti-insulin (a, b) or
anti-glucagon (c) antibodies. The sections were imaged by dfOCM com-
bined with a confocal fluorescent channel. (d) The signal-to-noise ratio
between the islets and the exocrine pancreas was quantified (n=50–60
islets per group). The outline of islets was defined by the structural OCM
signal and confirmed by IHC (a–c). Scale bar: 50 μm. ***p<0.001,
Mann–Whitney. SNR, signal-to-noise ratio
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Fig. 2 Longitudinal imaging of ACE-transplanted islets by FOCI and
quantification of beta cell volume and islet vascularisation in the healthy
state. Islets, transplanted into the ACE of BALB/c control mice (n=4),
were imaged by FOCI at the indicated time points and analysed for both
structure and dynamic blood flow variables in 3D. (a–d) Maximum
projection of the vascularisation and orthogonal view of the islet struc-
ture. (e) Islet volume at different time points normalised to the first time
point. (f) Islet vascular density (total vessel volume/total islet volume)
normalised to the first time point. For each time point, 5–12 islets were
analysed. Scale bar: 100 μm, colour bar indicates depth position in μm
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FOCI detects inflammation in pancreatic islets under au-
toimmune attack We next applied FOCI to follow the pro-
gressive autoimmune destruction of beta cells in the NOD
mouse model for type 1 diabetes. To determine if the cells
infiltrating the ACE-transplanted islets could be visualised in
a label-free manner using FOCI, we next analysed 14-week-
old non-diabetic NODmice transplanted with syngeneic islets
4 weeks prior to analysis.
As reported previously [21] and shown in Fig. 4, NOD
reporter mice can be used to visualise specific inflammatory
cellular populations infiltrating the pancreatic islet. To inter-
pret the altered OCM signal in vivo during the longitudinal
study, we used NOD.Foxp3-GFP reporter mice to visualise
the recruitment of forkhead box P3 (FOXP3)+ regulatory T
cells to the site of inflammation along with other inflamma-
tory leucocytes. The strong GFP signal indicating inflamma-
tion in the NOD islets, not observed in B6.Foxp3-GFP recip-
ient mice (Fig. 4a), matched completely the reduced FOCI
signal in the NOD islet (Fig. 4b). This supports the notion
that this approach could be used to discriminate the beta cell
volume from the infiltrated volume (Fig. 4b, ESM Fig. 4).
The B6 control mice did not show such alterations in the
FOCI signal. To confirm this, the mice were submitted to
conventional IHC of the grafted islet. As illustrated in
Fig. 4c and ESM Fig. 5, the insulin staining matched the
brighter part of the segmented xfOCM image, while the sig-
nificantly lower FOCI signal corresponded to the area stained
with a pan-leucocyte marker. These findings confirm that
FOCI can detect inflammation in addition to the beta cell
volume. While the high OCM signal is specific to insulin,
the lower OCM signal cannot be solely attributed to infiltra-
tion. Indeed, other non-beta endocrine cells and vessels also
give weaker scattering. To estimate the extent to which the
endocrine cell and vessel volume contribute to the non-beta
cell volume in inflamed islets, we tried to quantify the non-
beta cell volume in non-inflamed healthy wild-type islets.
After initial fluctuations of the non-beta cell volume shortly
after transplantation, it remained stable, making up approxi-
mately 3% of the total islet volume (ESM Fig. 6). While the
mean value of the non-beta cell volume in the non-inflamed
area is consistent with the literature [30], the significant de-
viation shows the limitation of FOCI technology for such a
small volume.
To confirm that the insulitis identified in the ACE-
transplanted NOD islets could be similarly detected by
OCM in the pancreas, we next analysed images of surgically
exposed pancreas from aged non-diabetic NOD mice. As il-
lustrated in Fig. 5a–c, we observed alterations in the refractory
a
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Fig. 3 Imaging of ACE-transplanted human islets by FOCI. Human
islets transplanted into the ACE of NOD.Rag2−/− mice (n=14 mice),
were imaged repeatedly for up to 25 weeks post transplantation. Shown
is a representative imaging session by FOCI at 8 weeks post transplanta-
tion. (a) Cryosection of the graft-bearing eye at 7 weeks post transplan-
tation stained with antibodies specific for insulin (red), glucagon (white)
and somatostatin (green). Nuclei are visualised by DAPI (blue). (b) Max-
imum projection of the vascularisation and orthogonal view of the islet
structure. Colour bar indicates depth position in μm. Scale bar: 100 μm
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Fig. 4 FOCI detects inflammation in ACE-transplanted islets affected by
insulitis. Islets transplanted into the ACE of 10-week-old NOD.Foxp3-
GFP recipients (n=12 mice) with ongoing insulitis or healthy B6.Foxp3-
GFP control mice (n=2 mice) were imaged by FOCI weekly. Shown is
one representative imaging session at 4 weeks (NOD) or 5 weeks (B6)
after transplantation. (a) Fluorescent widefield microscopy showing re-
cruitment of FOXP3-GFP+ Tcells in NOD but not in B6 control mice. (b)
FOCI recording showing structural information for the engrafted islet. (c)
Structural FOCI section segmented for beta cell signal (blue) and inflam-
mation (red) and cryosection (IHC) of the same graft-bearing eye (n=7
mice) at imaging endpoint stained with antibodies specific for insulin
(blue) and CD45 (red), GFP signal (FOXP3+ T cells) shown in green.
(d) Maximumprojection of the vascularisation. Scale bar: 100μm, colour
bar indicates depth position in μm
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pattern in some of the in situ imaged NOD islets, but not in
control B6 mice (Fig. 5d). This OCM signal was lower than
the signal detected in beta cells and different from the signal
detected from the exocrine tissue. These images potentially
reflected insulitis spanning from unaffected to peri-islet infil-
trates and full-blown intra-islet infiltration. By imaging thick
pancreatic sections of NODmice stained with a pan-leucocyte
marker (Fig. 6), we further confirmed that, as in the ACE
model, insulitis can be captured in situ by OCM in the
pancreas, though with the limitation of getting only single
snapshots of the disease.
Insulitis correlates with attenuated vascularisation density
Using the longitudinal FOCI platform, we next monitored the
vascular network of the islets during progressive inflammation
(Fig. 7). Ten-week-old recipient mice with an ongoing auto-
immune process were used, anticipating that the insulitis in the
ACE-transplanted islets of these mice would progress rapidly.
As expected, Foxp3-GFP+ cells were found to be recruited,
along with other inflammatory cells, to the islet graft and
accumulate over time (Fig. 7a), resulting in progressive beta
cell destruction. This is clearly distinguishable in the orthog-
onal FOCI view (Fig. 7b), which is additionally illustrated in a
3D representation (Fig. 7c–e, ESM Video 1-3) and quantified
(Fig. 7f).
As expected, we could visualise a gradual increase in the
total islet vascular network shortly after transplantation
(ESM Fig. 7). Counter intuitively, we noted a decrease in
the microvasculature density in infiltrated regions of in-
flamed islets, with only a few big vessels remaining
(Fig. 7a, g, h, Fig. 4d and ESM Videos 1–3). This decrease
in the microvasculature density was not observed in islets
displaying only limited infiltration (ESM Fig. 7 and ESM
Video 4), indicating that the observed attenuation of micro-
vasculature correlates with the severity of inflammation.
Additionally, an attenuation of the microvascular network
was observed in the inflamed islets imaged in situ in the
surgically exposed pancreases (Fig. 5a–c), but not in con-
trol B6 mice in situ (Fig. 5d) or B6 islet grafts in the ACE
(Fig. 2, Fig. 4d).
To confirm the regression of microvasculature observed by
FOCI, we used IHC to analyse sections of pancreatic islets
from aged non-diabetic NOD.Foxp3-GFP mice or ACE-
transplanted islets from the same mice (4 weeks post trans-
plantation) (see ESM Methods for details). This proves that
Non-infiltrated
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Fig. 5 OCM imaging of mouse
pancreas. Pancreas of prediabetic
NOD.Foxp3-GFP mice (n=6) (a–
c) or B6.Foxp3-GFP control mice
(n=2) (d) subjected to live
xfOCM imaging after
laparotomy. Maximum projection
of vascularisation and the
orthogonal view of islet structure
in insulitis (a, b), peri-insulitis (c)
and a non-inflamed control (d).
Arrows indicate blood vessels,
arrowheads indicate
inflammation. Scale bar 100 μm,
colour bar indicates depth
position in μm. Stripes in the
vascularisation images are due to
residual pancreas movements
OCM CD45 OCM/CD45
a
b
c
Fig. 6 Ex vivo OCM imaging of pancreas sections affected by insulitis.
Pancreas sections of 16-week-old NOD.Foxp3-GFP mice (n=3) were
fixed and subjected to IHC using the pan-leucocyte marker CD45 and
analysed by dfOCM and confocal microscopy (for imaging setup, see
ESM Fig. 1). Representative images show peri-insulitis (a), mild (b) or
massive insulitis (c). Scale bar: 100 μm
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the vessel density, as revealed by anti-CD31, was decreased in
inflamed areas compared with non-affected areas of the islets
(Fig. 8a–c, i). In contrast, high endothelial venules (HEVs)
[31] expressing mucosal addressin cell adhesion molecule 1
(MAdCAM-1) predominated within inflamed islet areas
(Fig. 8e–g, j). This supports previous observations of
lymphocyte-HEV recognition in the development of insulitis
in NOD mice [8, 15, 32, 33]. Interestingly, a similar distribu-
tion of CD31+ vs HEVs was also seen in inflamed ACE-
transplanted NOD islets (Fig. 8d, h, i, j).
Discussion
Our label-free 3D images are based on next-generation
OCM, denoted functional optical coherence imaging for
its substantial extension into functional imaging. Com-
pared with related imaging techniques such as OCT [34]
or optical frequency domain imaging (OFDI) [35], FOCI
has a micrometric resolution over an extended depth range.
In contrast to conventional confocal microscopy, FOCI of-
fers several advantages for islet imaging. First, it allows
for simultaneous, label-free imaging of the islet structure
and the vasculature. As the FOCI contrast is caused by the
intrinsic light scattering of tissue it does not require genet-
ically modified mice or an extrinsic biomarker to detect the
beta cell volume and functional vascularisation. In addi-
tion, it is not affected by autofluorescence. Second, the
coherent amplification of the backscattered light results
in a higher signal-to-noise ratio. This increased contrast
enables quantitative segmentation of the beta cell volume,
vascularisation and infiltration. Third, the multiplex ad-
vantage of FOCI translates into a parallel acquisition of
depth profiles, circumventing the need for voxel per voxel
scanning in depth. The fast acquisition increases the time
resolution allowing for visualising the vasculature of
h
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Fig. 7 Longitudinal quantification of insulitis and the impact on vascu-
larisation. Islets, transplanted into the ACE of 10-week-old
NOD.Foxp3-GFP reporter mice (n=12) with ongoing insulitis, were im-
aged weekly. Shown are representative imaging sessions of the same islet
at 1 week, 3 weeks and 4 weeks. (a) Live widefield fluorescence imaging
and maximum projection of vascularisation. (b) Orthogonal view of a 3D
stack of the islet graft at weeks 1–4. (c) Overlay of vasculature (red) and
beta cell volume (green). (d) Segmented beta cell volume (green) and
inflammation volume (blue) or (e) inflammation volume alone. (f)
Quantification of inflammation volume per islet volume over time (n=
5). (g) Relative density of vascularisation in inflamed volumes of the islet
(blue in d) compared with non-affected beta cell volume (green in d) at
4 weeks (n=5 islets), see also ESMMethods. (h) FOCI section of vascu-
lature alone or merged with islet structure. Scale bar: 100 μm, colour-
coded bar indicates depth position in μm. *p<0.05 and **p<0.01,
Mann–Whitney test. βCV, beta cell volume; infl., inflammation; vasc.,
vasculature; w, week
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whole islets in 30 s. By applying the phase sensitivity of
FOCI, blood flow can be quantified, a critical variable to
monitor during the progression of diabetes. Finally, FOCI
uses a broadband near infra-red (NIR) light source
(<5 mW on the cornea) to acquire a full depth, resulting
in a substantially lower power exposure and minimises the
risk of photo-damage of fragile islet structures and
microvasculature.
The lack of direct, non-invasive technologies to visual-
ise inflammation in the pancreas has been a key obstacle to
the early detection of type 1 diabetes and the rapid
assessment of the effectiveness of therapeutic intervention.
To highlight the usefulness of FOCI applied to the ACE
model, we analysed and compared islets from a mouse
model of type 1 diabetes. The location and anatomy of
the pancreas make the study of this disease at the organ
level difficult, requiring compromises on resolution for
longitudinal studies in the timescale of disease progres-
sion. While direct examination of fixed pancreases has
yielded valuable insight into the processes leading to dia-
betes, such classic attempts only provide a snapshot of the
disease. Thus, non-invasive imaging strategies to monitor
changes within the islets associated with diabetes are being
sought to fill this gap. By applying the FOCI technique, we
revealed several surprising features of the disease.
The longitudinal recording of the autoimmune-induced
islet alterations in the ACE provided detailed monitoring
and quantification of the decreasing beta cell volume and
of the impact on the islet vasculature during the inflamma-
tory process. An observed decrease in the vascular density
in areas affected by insulitis coincided with a promotion of
MAdCAM-1-expressing HEV-like structures. Altered vas-
culature has previously been associated with type 1 diabe-
tes [2–4, 36]. More specifically, Villalta et al [36] have
reported an increase rather than a decrease in vasculature
when comparing pancreases from NOD mice prior to
insulitis onset and NOD mice with advanced insulitis. This
apparently conflicting statement may, in part, be due to
differences in the overall assessment. We compared the
vascularisation of infiltrated and non-infiltrated areas on
the same individual islets, whereas Villalta et al [36] ob-
served the increase in vasculature comparing the whole
islets isolated from 4-week-old NOD mice with 18-week-
old NOD mice. We therefore argue that the increase in
vasculature under those conditions may be part of a devel-
opmentally controlled increase in islet vascularisation.
HEVs have been linked to the promotion of guidance of
lymphocyte trafficking and recruitment into inflammatory
sites [31]. The observed overall reduction in the microvas-
culature is counterintuitive and remains to be understood in
the larger framework of its impact on the pathogenesis of
autoimmune diabetes.
The label-free detection of beta cell volume and vascular-
isation offered by the FOCI technique provides the unique
possibility of studying ACE-transplanted human islets. Inter-
estingly, the acceptance rate of xenografting human islets to
NOD.Rag2−/− mice was similar to that of grafting syngeneic
NOD islets. This may be surprising, as recombination acti-
vating gene 2 (RAG2)-deficient mice have been shown to
retain functional natural killer (NK) cells, which have been
suggested to contribute to xenograft rejection [37]. However,
the role of NK cells in the rejection of xenotransplanted
solid organs remains debated [38] and we cannot fully
explain the mechanisms.
Fig. 8 Confirmation of the attenuation of microvasculature in insulitic
areas by IHC and the identification of HEVs. IHC of transplanted eye and
pancreas samples from 14-week-old NOD.Foxp3-GFP reporter mice (n=
7) 4 weeks after transplantation, demonstrating the attenuated microvas-
culature by immunostaining for CD31 (a–d) and identification of HEVs
by MAdCAM-1 staining (e–h). Beta cell areas were identified by insulin
(blue line) and inflamed areas by the pan-leucocyte marker CD45 (cyan
line) or DAPI. GFP signal (FOXP3+ T cells, a–d) is shown in green and
glucagon staining in cyan (a–d). Representative images of the same NOD
pancreas (a–c, e–g): unaffected (c, g); with mild insulitis (b, f); and with
full-blown insulitis (a, e). Quantification of CD31+ (i) or MAdCAM-1+
(j) vessel density (vessels/mm2) in insulin-positive islet areas compared
with inflamed islet areas (n=13–23 islet sections, 5–6 mice, see ESM
Methods for further details). ***p<0.001; scale bars: 100 μm. w, weeks
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